المؤلفون: Bäuml J; Hospital of Psychiatry and Psychotherapy, Technical University of Munich, Munich, Germany J.Baeuml@lrz.tum.de., Pitschel-Walz G; Hospital of Psychiatry and Psychotherapy, Technical University of Munich, Munich, Germany., Volz A; Hospital of Psychiatry and Psychotherapy, Technical University of Munich, Munich, Germany., Lüscher S; Hospital of Psychiatry and Psychotherapy, Technical University of Munich, Munich, Germany., Rentrop M; Hospital of Psychiatry and Psychotherapy, Technical University of Munich, Munich, Germany., Kissling W; Hospital of Psychiatry and Psychotherapy, Technical University of Munich, Munich, Germany., Jahn T; Hospital of Psychiatry and Psychotherapy, Technical University of Munich, Munich, Germany.

المصدر: Schizophrenia bulletin [Schizophr Bull] 2016 Jul; Vol. 42 Suppl 1, pp. S62-70. Date of Electronic Publication: 2016 Mar 08.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0236760 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-1701 (Electronic) Linking ISSN: 05867614 NLM ISO Abbreviation: Schizophr Bull Subsets: MEDLINE

مواضيع طبية MeSH: Outcome Assessment, Health Care*, Antipsychotic Agents/*pharmacology , Antipsychotic Agents/*therapeutic use , Medication Adherence/*psychology , Patient Education as Topic/*methods , Psychotic Disorders/*drug therapy , Schizophrenia/*drug therapy , Tardive Dyskinesia/*chemically induced, Adult ; Antipsychotic Agents/administration & dosage ; Antipsychotic Agents/adverse effects ; Chlorpromazine/administration & dosage ; Chlorpromazine/adverse effects ; Chlorpromazine/pharmacology ; Female ; Follow-Up Studies ; Germany ; Humans ; Male ; Middle Aged

المؤلفون: Behnes M; First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany. Electronic address: michael.behnes@umm.de., Bertsch T; Institute of Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, General Hospital Nuremberg, Paracelsus Medical University, Nuremberg, Germany., Weiss C; Department for Statistical Analysis, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany., Ahmad-Nejad P; Institute for Microbiology and Laboratory Medicine, HELIOS Klinikum Wuppertal, University of Witten/Herdecke, Wuppertal, Germany., Akin I; First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany., Fastner C; First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany., El-Battrawy I; First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany., Lang S; First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany., Neumaier M; Institute for Clinical Chemistry, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany., Borggrefe M; First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany., Hoffmann U; First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.

المصدر: International journal of cardiology [Int J Cardiol] 2016 Jan 15; Vol. 203, pp. 398-406. Date of Electronic Publication: 2015 Oct 20.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8200291 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1874-1754 (Electronic) Linking ISSN: 01675273 NLM ISO Abbreviation: Int J Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Galectin 3/*blood , Heart Failure/*blood , Intercellular Signaling Peptides and Proteins/*blood , Osteopontin/*blood, Acute Disease ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biomarkers/blood ; Disease Progression ; Echocardiography, Doppler, Color ; Enzyme-Linked Immunosorbent Assay ; Female ; Follow-Up Studies ; Germany/epidemiology ; Heart Failure/diagnosis ; Heart Failure/mortality ; Humans ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Survival Rate/trends ; Time Factors ; Young Adult